Evidence map›Paper›PMID 30707402›Full record

ArticleJournal of molecular neuroscience : MN2019

Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.

Sadaf Munir, Rabia Habib, Sliha Awan, Nazia Bibi, Arooj Tanveer, Sajida Batool, Syed M Nurulain

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sadaf MunirDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan.
Rabia HabibDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan. rabiahabib@comsats.edu.pk.
Sliha AwanDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan.
Nazia BibiDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan.
Arooj TanveerDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan.
Sajida BatoolDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan.
Syed M NurulainDepartment of Biosciences, Functional Proteomics and Genomics Lab, COMSATS University Islamabad, Islamabad, Pakistan. syed.nurulain@comsats.edu.pk.ORCID http://orcid.org/0000-0001-6146-1511
COMSATS University Islamabad · PK

Funding

COMSATS Institute of Information Technology (PK) #16-20/CRGP/CIIT/IBD/16
6 · The paper itself

Abstract

Addiction is a complex mental and behavioral disorder that changes the neurochemistry and physiology of the brain. Genetics also plays a significant role in the pathophysiology of addiction. Butyrylcholinesterase (BChE), a cholinergic enzyme, has been implicated in the metabolism of various drugs, including cocaine, and an association between single-nucleotide polymorphisms (SNPs) of the butyrylcholinesterase gene (BCHE) and neuronal disorders has been reported. We report here the first investigation to be conducted on the status of BChE activity and the potential association of two BCHE gene SNPs, rs3495 (c.*189G > A) and rs1803274 (c.1699G>A, p.Ala567Thr, K-variant), with addiction vulnerability in heroin, hashish and polydrug users. Seventy-five individuals with an addiction to heroin, hashish and/or polydrug use were recruited to this study. BChE levels in the plasma were determined by Ellman's principle. SNPs were genotyped by standard procedures, followed by Sanger sequencing. Plasma BChE levels were found to be significantly higher (p ≤ 0.05) in addicts (mean ± standard error of the mean 0.031 ± 0.004 μmol/L/min; 95% confidence interval [CI] 0.024-0.038) than in non-addicts (controls) (0.014 ± 0.001 μmol/L/min; 95% CI 0.012-0.017). Statistical significant differences were also observed between the addicted cohorts. A statistically significant association for both SNPs (rs3495 and rs1803274) was not observed in addicted subjects tested in the dominant, recessive and allele genetic models, but trends of variations of the rs3495 risk G allele were noted. The authors conclude that BChE plays significant roles in addiction pathophysiology as increased BChE activity in blood samples obtained from the cohorts with addiction was evident. Further studies in this direction may provide novel approaches for the treatment of addiction, but studies with a larger sample size and different ethnic groups are warranted for broader conclusions to be drawn.

Indexed as

Polymorphism, Single NucleotideAdultButyrylcholinesteraseHumansMaleSubstance-Related DisordersButyrylcholinesteraseButyrylcholinesteraseHashishPolydrugrs1803274rs3495Substance abuse

Identifiers

PMID30707402
OpenAlexW2913348578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.